Bristol-Myers Squibb Co
XETRA:BRM

Watchlist Manager
Bristol-Myers Squibb Co Logo
Bristol-Myers Squibb Co
XETRA:BRM
Watchlist
Price: 48.27 EUR -0.8% Market Closed
Market Cap: 97.9B EUR

Intrinsic Value

The intrinsic value of one BRM stock under the Base Case scenario is hidden EUR. Compared to the current market price of 48.27 EUR, Bristol-Myers Squibb Co is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

BRM Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Bristol-Myers Squibb Co

Intrinsic Value History
Dive into the past to invest in the future

BRM looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if BRM is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about BRM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is BRM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Bristol-Myers Squibb Co.

Explain Valuation
Compare BRM to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Heightened patent-expiration risk and revenue concentration around key drugs like Revlimid and Eliquis could sharply reduce Bristol-Myers Squibb’s cash flows, limiting its ability to fund pipeline development.

Bull Theses

Bristol-Myers Squibb holds a leading position in immuno-oncology with proven blockbusters like Opdivo and Yervoy, providing a strong base of recurring revenue and brand recognition.

Show More Less
How do you feel about BMY?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Bristol-Myers Squibb Co

Current Assets 35.6B
Cash & Short-Term Investments 16.5B
Receivables 14.6B
Other Current Assets 4.5B
Non-Current Assets 61.3B
Long-Term Investments 2.3B
PP&E 9B
Intangibles 42.2B
Other Non-Current Assets 7.8B
Current Liabilities 28.1B
Accounts Payable 4.3B
Accrued Liabilities 15B
Short-Term Debt 261m
Other Current Liabilities 8.6B
Non-Current Liabilities 50.2B
Long-Term Debt 44.5B
Other Non-Current Liabilities 5.7B
Efficiency

Free Cash Flow Analysis
Bristol-Myers Squibb Co

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Bristol-Myers Squibb Co

Revenue
48B USD
Cost of Revenue
-12.9B USD
Gross Profit
35.1B USD
Operating Expenses
-19B USD
Operating Income
16.1B USD
Other Expenses
-10.1B USD
Net Income
6B USD
Fundamental Scores

BRM Profitability Score
Profitability Due Diligence

Bristol-Myers Squibb Co's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional ROE
Exceptional Operating Margin
Exceptional Gross Margin
ROE is Increasing
hidden
Profitability
Score

Bristol-Myers Squibb Co's profitability score is hidden . The higher the profitability score, the more profitable the company is.

BRM Solvency Score
Solvency Due Diligence

Bristol-Myers Squibb Co's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Positive Net Debt
Average Altman Z-Score
hidden
Solvency
Score

Bristol-Myers Squibb Co's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BRM Price Targets Summary
Bristol-Myers Squibb Co

Wall Street analysts forecast BRM stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BRM is 47.16 EUR with a low forecast of 28.52 EUR and a high forecast of 60.92 EUR.

Lowest
Price Target
28.52 EUR
41% Downside
Average
Price Target
47.16 EUR
2% Downside
Highest
Price Target
60.92 EUR
26% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BMY is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

BMY Insider Trading
Buy and sell transactions by insiders

BRM News

Other Videos
What is the Intrinsic Value of one BRM stock?

The intrinsic value of one BRM stock under the Base Case scenario is hidden EUR.

Is BRM stock undervalued or overvalued?

Compared to the current market price of 48.27 EUR, Bristol-Myers Squibb Co is hidden .

Back to Top